Caladrius Biosciences, Inc. - Common Stock (NQ:CLBS)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 14, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Caladrius Biosciences, Inc. - Common Stock

< Previous 1 2 Next >

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday ↗

September 15, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 14, 2022

Via Benzinga

Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study ↗

May 24, 2022

Via Benzinga

Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics ↗

April 27, 2022

Via Benzinga

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2022

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 02, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 02, 2022

We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket ↗

September 02, 2022

Gainers

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

CALADRIUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS

August 03, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Earnings Outlook For Caladrius Biosciences ↗

August 03, 2022

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Caladrius Biosciences's Earnings Outlook ↗

August 03, 2022

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

July 28, 2022

From Caladrius Biosciences, Inc.

Via GlobeNewswire

The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures ↗

May 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

CALADRIUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS

May 05, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

74 Biggest Movers From Yesterday ↗

April 29, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...

Via Benzinga

48 Stocks Moving In Thursday's Mid-Day Session ↗

April 28, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution. Statera...

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

April 28, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares rose 103.3% to $4.27 in pre-market trading after gaining over 8% on Wednesday. Trust Stamp recently posted Q4 net sales of $2.1...

Via Benzinga

CLBS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Caladrius Biosciences, Inc. Is Fair to Shareholders

April 27, 2022

From Halper Sadeh LLP

Via Business Wire

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale ↗

March 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Recap: Caladrius Biosciences Q4 Earnings ↗

March 23, 2022

Caladrius Biosciences (NASDAQ:CLBS) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:30 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout ↗

March 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 22, 2022 ↗

March 22, 2022

Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (...

Via Benzinga

Caladrius Biosciences Earnings Preview ↗

March 21, 2022

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 18, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc...

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

January 05, 2022

Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 04, 2022

Gainers Hoth Therapeutics (NASDAQ:

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.